AstraZeneca | AZN - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
14,537.00
Cambio Giornaliero
-237.00 -1.60%
Mensile
4.67%
Annuale
20.42%
Q1 Previsione
15,229.61




Spese Di Vendita E Di Amministrazione Cambiamento Data
AbbVie USD 3.89B 325M 2025-12
Alcon AG USD 901M 36M 2025-12
Amgen USD 1.94B 237M 2025-12
argenx SE USD 429.62M 93.32M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Autolus Therapeutics Ltd USD 27.96M 1.58M 2025-06
Bayer EUR 4.05B 647M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 785M 79.56M 2025-12
Galapagos EUR 44.42M 9.87M 2025-12
Genmab DKK 144M 18M 2025-06
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
GRIFOLS EUR 275.3M 9.7M 2025-12
Haleon GBP 1.08B 11M 2025-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Merck EUR 1.46B 16M 2025-09
Merck USD 2.85B 215M 2025-12
Novartis USD 3.31B 134M 2025-09
Orion EUR 110.7M 26.1M 2025-12
Pfizer USD 4.08B 894M 2025-12
Philips EUR 1.31B 127M 2025-12
Recordati EUR 171.38M 15.6M 2025-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.75B 455M 2025-12
UCB EUR 1.29B 221M 2024-12